NOVO NORDISK: THE TRIPLE BOTTOM LINE11This case study was written by Jocelyn E. Mackie under the supervision of Abdallah S. Daar. All data for this case come from interviews performed by Daar and Mackie on March 15–17, 2004, at Novo Nordisk, unless otherwise noted. This case is one in a series produced under grants funded by The Seaver Institute and Genome Canada to study models for ensuring ethical decision making in bioscience firms. We would like to thank all the employees of Novo Nordisk who took part in this study.
1997 ◽
Vol 9
(1)
◽
pp. 115-122
Keyword(s):
Keyword(s):